Millions of Brits are now eligible for the appetite-suppressing jabs which can come with unpleasant side effects - but NHS rationing means only a tiny fraction will be prescribed them ...

Ozempic, the drug that was originally approved to treat type 2 diabetes, has now also been approved by the FDA to reduce ...

The American Idol star and Christian singer died at age 47 from complications of class III obesity, according to PEOPLE.

These high-quality stocks continuously grow, maintain an edge over competitors, and make more money than the business needs.

Despite the study being short, and people taking the drugs for only 3.5 years because of how new they are ... altering the ...

BioAge has also entered a strategic collaboration with Lilly ExploR&D (part of Lilly Catalyze360) to discover two therapeutic antibodies that address novel metabolic aging targets identified by BioAge ...

Advancement of next-generation APJ agonists with discontinuation of azelaprag Nomination of NLRP3 inhibitor BGE-102 as a development candidate, with initial Ph1 clinical data anticipated by end of 202 ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat ...

NEW YORK--(BUSINESS WIRE)--Metsera, Inc., a clinical-stage biopharmaceutical company accelerating the next generation of medicines for obesity and ... body weight of 11.3% (placebo-adjusted ...

Horizon Organic Dairy has recalled 19,688 cases of its 12-pack and individually packaged 8-ounce Horizon Organic Aseptic ...

Moreover, the list of 15 is expected to include the blockbuster drug semaglutide, the GLP-1 class drug behind the ... and stroke in adults with either obesity or overweight. But, in November ...

Projections about the coming year assume market shifts will be dictated by Donald Trump. But the global economy is unlikely to revolve around the US ...